Low-Dose Tirzepatide Matched 5 mg on Weight Loss in a 112-Patient Japanese Cohort
A non-randomised Japanese cohort found 2.5 mg and 5 mg tirzepatide produced statistically indistinguishable weight loss at six months, with fewer adverse events at the lower dose — one of several late-July reports reframing where the dual agonist's dose ceiling sits.
2 August 20269 min read
